Dales Laboratories P Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.50 M
as on 11-12-2024
- Company Age 41 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 M
as on 11-12-2024
- Satisfied Charges ₹ 1.21 Cr
as on 11-12-2024
- Revenue 52.91%
(FY 2022)
- Profit 110.54%
(FY 2022)
- Ebitda 94.70%
(FY 2022)
- Net Worth 20.65%
(FY 2022)
- Total Assets 37.16%
(FY 2022)
About Dales Laboratories P
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.00 M. The company has closed loans amounting to ₹1.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bernard Remedios, Sabina Fernandes, and Vinayak Mulgaonkar serve as directors at the Company.
- CIN/LLPIN
U24239MH1983PTC030091
- Company No.
030091
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 May 1983
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dales Laboratories P?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bernard Remedios  | Director | 30-May-1983 | Current |
| Sabina Fernandes | Director | 14-Feb-2009 | Current |
| Vinayak Mulgaonkar | Director | 10-Dec-2014 | Current |
Financial Performance of Dales Laboratories P.
Dales Laboratories P Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 52.91% increase. The company also saw a substantial improvement in profitability, with a 110.54% increase in profit. The company's net worth Soared by an impressive increase of 20.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dales Laboratories P?
Unlock access to Dales Laboratories P's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Vijaya Bank Creation Date: 20 Sep 1995 | ₹2.00 M | Open |
Bank Of Maharashtra Creation Date: 26 Aug 2010 | ₹2.20 M | Satisfied |
Bank Of Maharashtra Creation Date: 20 Aug 2010 | ₹2.20 M | Satisfied |
How Many Employees Work at Dales Laboratories P?
Unlock and access historical data on people associated with Dales Laboratories P, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dales Laboratories P, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dales Laboratories P's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
